newsfilter
← Latest News
Business Wire·

Athersys Announces Successful Type B Meeting with the FDA

Primary Endpoint in Pivotal Acute Ischemic Stroke Trial Will Become mRS Shift Analysis at Day 365 Modifications Reflect Observations from Healios' Recently Completed TREASURE Trial in Japan and the Evolution of